The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.
Patients who require dialysis are at high risk for cardiovascular mortality, which may be improved by mineralocorticoid receptor antagonists (MRAs).Systematic review and meta-analysis of randomized controlled trials.Adults undergoing long-term hemodialysis or peritoneal dialysis with or without hear...
Main Authors: | Quach, K, Lvtvyn, L, Baigent, C, Bueti, J, Garg, A, Hawley, C, Haynes, R, Manns, B, Perkovic, V, Rabbat, C, Wald, R, Walsh, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2016
|
Similar Items
-
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01) -
Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01) -
Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01) -
Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
by: Monarch Shah, et al.
Published: (2023-09-01) -
Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
by: Wiktoria Baran, et al.
Published: (2021-09-01)